Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by N Gossai
A Clofarabine-Based Bridging Regimen in Patients With Relapsed ALL and Persistent Minimal Residual Disease (MRD)
Bone Marrow Transplantation
Transplantation
Hematology
Similar Outcomes Between Adolescent/Young Adults and Children With AML Following Allogeneic Hematopoietic Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Monitoring of Minimal Residual Disease (MRD) Is Useful to Predict Prognosis of Adult Patients With Ph-Negative ALL: Results of a Prospective Study (ALL MRD2002 Study)
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Measurable Residual Disease (MRD) Detection by Next Generation Sequencing (NGS) in Acute Lymphoblastic LEUKAEMIA (ALL)
Pathology
Forensic Medicine
Pathology
Transcend CLL 004: Minimal Residual Disease After Lisocabtagene Maraleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Minimal Residual Disease (Mrd) in Non‐hodgkin Lymphomas: Inter‐laboratory Reproducibility on Marrow Samples With Very Low Levels of Disease Within the Fil (Fondazione Italiana Linfomi) MRD Network
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Minimal Residual Disease
Leukemia Supplements
Minimal Residual Disease
Bone Marrow Transplantation
Transplantation
Hematology
Minimal Residual Disease (Mrd) in Early Stage Follicular Lymphoma Can Predict Prognosis and Drive Rituximab Treatment After Radiotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Preventing Relapse After Haematopoietic Stem Cell Transplantation for Acute Leukaemia: The Role of Post-Transplantation Minimal Residual Disease (MRD) Monitoring and MRD-directed Intervention
British Journal of Haematology
Hematology
A Retrospective Study of Blinatumomab Based Salvage Regimen as a Bridge to Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients With Relapsed and Refractory ALL
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
